Objective
To provide comprehensive conference coverage focused on Liquid Biopsy technologies, delivering actionable competitive intelligence (CI) insights for pharmaceutical and biotechnology clients. The goal was to track emerging assays, pipeline candidates, and strategic developments in the liquid biopsy domain.
Stay informed on the latest innovations and competitor activity in liquid biopsy with DelveInsight’s conference coverage services.
Problem Statement
A global pharmaceutical client required timely and structured insights from major oncology and diagnostics conferences, focusing on:
-
Emerging liquid biopsy assays and technologies
-
Key competitor data and pipeline updates
-
Clinical trial readouts and study outcomes
-
Strategic partnerships, collaborations, and regulatory updates
-
Expert perspectives from Key Opinion Leaders (KOLs)
The client needed a reliable solution to gather, synthesize, and interpret large volumes of conference data, translating it into actionable business intelligence for research, development, and commercial planning.
Our Methodology
Pre-Conference Planning:
-
Identified high-priority sessions, abstracts, and presentations relevant to liquid biopsy.
-
Developed Key Intelligence Topics (KITs) and Key Intelligence Questions (KIQs) to guide data collection.
Live Conference Monitoring:
-
Analysts and subject matter experts tracked presentations, posters, and symposia in real time.
-
Captured competitor updates, clinical findings, technology trends, and regulatory discussions.
Post-Conference Analysis:
-
Synthesized findings into a structured report highlighting pipeline trends, competitor positioning, and emerging technologies.
-
Evaluated the clinical and commercial impact of new data on the liquid biopsy landscape.
KOL Insights:
-
Collected expert opinions on emerging technologies, clinical utility, and potential market adoption.
-
Integrated stakeholder perspectives to assess scientific and business relevance.
Deliverables:
-
Comprehensive conference intelligence report with actionable insights.
-
Interactive dashboard summarizing competitors, products, and trends.
-
Strategic recommendations to support R&D prioritization and commercial strategy.
Results
-
Complete Competitive Visibility: Provided a detailed view of emerging technologies, market entrants, and pipeline developments.
-
Strategic Agility: Allowed the client to respond proactively to competitor advancements and market shifts.
-
Actionable Insights: Delivered clear recommendations for R&D focus, partnerships, and commercialization strategies.
-
Continuous Updates: Ensured ongoing post-conference intelligence for sustained competitive monitoring.
Contact us today to learn how our insights can support your competitive intelligence strategy in liquid biopsy and oncology diagnostics.
About Delveinsight
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Contact Us
Kanishk
kkumar@delveinsight.com